Effects of combined immunosuppressive, anticoagulant and antiaggregant treatment on the course of chronic membranoproliferative glomerulonephritis.
Dimitrakov
D
D
Clinic of Nephrology, Higher Medical Institute, Plovdiv, Bulgaria.
Simeonov
S
S
Despotov
T
T
Kumchev
E
E
Tsvetkova
Z
Z
D000328:Adult; D003520:Cyclophosphamide / Q000008:administration & dosage; D004176:Dipyridamole / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage
D004176:Dipyridamole; D003520:Cyclophosphamide; D006493:Heparin; D011241:Prednisone; D008775:Methylprednisolone